Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Erlotinib in Combination With Bortezomib

This study has been completed.
Information provided by (Responsible Party):
M.D. Anderson Cancer Center Identifier:
First received: May 6, 2009
Last updated: July 10, 2015
Last verified: July 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)